A practical buyer’s guide: 12 questions pharma and biotech companies should ask when evaluating AI-powered regulatory technology platforms.
FDA 21 CFR Part 11 compliance isn’t optional for life sciences companies managing electronic records. Yet many organizations only think about compliance when an audit is imminent—leading to stressful scrambles and potential findings. This guide provides a systematic approach to audit preparation that regulatory operations leaders can implement today. Understanding What FDA Inspectors Look For […]
For Regulatory Operations Leaders: Building a Technology Strategy That Scales If you lead regulatory operations at a growing pharma or biotech company, you have likely been handed a mandate that sounds simple and is not: modernize the technology stack, reduce submission cycle times, and do it without disrupting the work that is already in flight. […]
Multi-Tenant Architecture: Why It Matters for CROs and Enterprise Regulatory Teams If you manage regulatory operations for a CRO or a multi-unit enterprise, you have almost certainly encountered this tension: the need to share infrastructure for efficiency versus the absolute requirement to keep data separate for compliance, confidentiality, and sponsor trust. Legacy on-premise publishing and […]
DnXT platform transforms regulatory operations by leveraging modern technology to address evolving compliance requirements, faster approval timelines, and increasing data complexity in organizations.
DnXT helps life sciences companies navigate the massive technological transformation in regulatory operations, moving from outdated processes to streamlined systems where documents and workflows actually communicate effectively.
Enterprise RIM platforms are overbuilt and overpriced for growing biotech. DnXT is cloud-native eCTD publishing built for the companies the big guys ignore.